Literature DB >> 15875131

Negative inotropic action of propofol is enhanced in the acute ischemic myocardium of dogs.

Takuji Maekawa1, Sungsam Cho, Shunji Takahashi, Tetsuya Hara, Shiro Tomiyasu, Tetsuji Makita, Koji Sumikawa.   

Abstract

PURPOSE: We investigated the effects of propofol on contractility and oxygen balance in acute ischemic myocardium and compared them with those of normal myocardium using a coronary microembolization model in dogs.
METHODS: In open-chest dogs, the left anterior descending coronary artery (LAD) was perfused through an extracorporeal bypass from the carotid artery. Regional myocardial contractility and myocardial oxygen balance were evaluated along with segment shortening (%SS), regional myocardial oxygen consumption (MVO2), and lactate extraction ratio (LER) of the area perfused by the LAD. Acute ischemia was produced by repeated injection of microspheres into the LAD-perfused area until %SS decreased by 50% of baseline.
RESULTS: In normal myocardium, intracoronary infusion of propofol at doses of 1.2 and 2.4 mg x kg(-1) x h(-1) caused slight decreases in %SS to 83% +/- 8% and 80% +/- 10%, respectively. In ischemic myocardium, propofol caused greater decreases in %SS (59% +/- 18% and 35% +/- 20%, respectively). The changes in MVO2 after propofol infusion generally paralleled the changes in %SS, but LER was not changed in either ischemic or normal myocardium.
CONCLUSION: Propofol causes a greater decrease in the contractility of acute ischemic myocardium as compared with normal myocardium in which myocardial oxygen imbalance is not involved as a mechanism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15875131     DOI: 10.1007/s00540-005-0304-6

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  1 in total

Review 1.  Propofol for sedation for direct current cardioversion.

Authors:  Bruna Galvão de Wafae; Rose Mary Ferreira da Silva; Henrique Horta Veloso
Journal:  Ann Card Anaesth       Date:  2019 Apr-Jun
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.